Skip to main content
Equibles

Seven Fleet Capital Management LP

Position in SMMT — Summit Therapeutics Inc.

CIK 2092021 MOUNTAIN VIEW, CA
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$1,067,981
New position
Shares Held
73,300
first reported quarter
Ownership
0.009%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#85
of 242 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Seven Fleet Capital Management LP holds $585,168,790 across 88 Biotechnology names. SMMT ranks #55 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 1,886,236 $134,017,067
2 TNGX
Tango Therapeutics, Inc.
 3,228,144 $100,911,781
3 RVMD
Revolution Medicines, Inc.
 242,029 $45,327,190
4 PHVS
Pharvaris N.V.
 774,501 $26,782,243
5 ELVN
Enliven Therapeutics, Inc.
 365,386 $18,543,339
6 ABVX
Abivax S.A.
 111,334 $14,836,368
7 AVTX
Avalo Therapeutics, Inc.
 770,765 $14,243,736
8 MIRM
Mirum Pharmaceuticals, Inc.
 110,393 $12,923,708

All Filings in SMMT

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $1,067,981 73,300